JPMorgan Chase & Co’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,542,476
Closed -$31.1M 6139
2021
Q3
$31.1M Buy
1,542,476
+110,950
+8% +$2.24M ﹤0.01% 1299
2021
Q2
$53.4M Buy
1,431,526
+397,902
+38% +$14.8M 0.01% 1099
2021
Q1
$26.4M Buy
1,033,624
+234,315
+29% +$5.99M ﹤0.01% 1388
2020
Q4
$17.6M Buy
799,309
+206,171
+35% +$4.54M ﹤0.01% 1521
2020
Q3
$10.9M Buy
593,138
+81,449
+16% +$1.5M ﹤0.01% 1728
2020
Q2
$13M Buy
511,689
+54,583
+12% +$1.39M ﹤0.01% 1531
2020
Q1
$8.4M Sell
457,106
-107,805
-19% -$1.98M ﹤0.01% 1672
2019
Q4
$12.4M Buy
564,911
+97,622
+21% +$2.15M ﹤0.01% 1639
2019
Q3
$6.71M Sell
467,289
-10,035
-2% -$144K ﹤0.01% 2022
2019
Q2
$7.52M Buy
477,324
+31,602
+7% +$498K ﹤0.01% 1903
2019
Q1
$6.53M Buy
445,722
+431,984
+3,144% +$6.33M ﹤0.01% 1957
2018
Q4
$147K Sell
13,738
-45,280
-77% -$485K ﹤0.01% 3906
2018
Q3
$900K Buy
59,018
+7,238
+14% +$110K ﹤0.01% 3234
2018
Q2
$634K Sell
51,780
-69,168
-57% -$847K ﹤0.01% 3350
2018
Q1
$1.16M Buy
120,948
+85,525
+241% +$817K ﹤0.01% 3011
2017
Q4
$320K Buy
35,423
+33,823
+2,114% +$306K ﹤0.01% 3521
2017
Q3
$8K Sell
1,600
-1,770
-53% -$8.85K ﹤0.01% 4086
2017
Q2
$11K Buy
3,370
+1,270
+60% +$4.15K ﹤0.01% 4035
2017
Q1
$7K Buy
+2,100
New +$7K ﹤0.01% 4260
2016
Q4
Sell
-13,278
Closed -$78K 4591
2016
Q3
$78K Sell
13,278
-6,864
-34% -$40.3K ﹤0.01% 3486
2016
Q2
$60K Sell
20,142
-104,558
-84% -$311K ﹤0.01% 3500
2016
Q1
$669K Sell
124,700
-2,925
-2% -$15.7K ﹤0.01% 2823
2015
Q4
$1.51M Sell
127,625
-10,850
-8% -$129K ﹤0.01% 2512
2015
Q3
$1.14M Sell
138,475
-17,175
-11% -$141K ﹤0.01% 2625
2015
Q2
$2.17M Sell
155,650
-59,625
-28% -$832K ﹤0.01% 2482
2015
Q1
$5.17M Sell
215,275
-88,350
-29% -$2.12M ﹤0.01% 2089
2014
Q4
$5M Sell
303,625
-47,325
-13% -$779K ﹤0.01% 2058
2014
Q3
$4.47M Sell
350,950
-4,625
-1% -$58.9K ﹤0.01% 2075
2014
Q2
$8.03M Buy
355,575
+92,450
+35% +$2.09M ﹤0.01% 1813
2014
Q1
$7.43M Buy
+263,125
New +$7.43M ﹤0.01% 1845